Palo Alto Investors LP
Overview
Palo Alto Investors LP is a physician-led investment firm specializing in healthcare equities. Founded in 1989, the firm conducts deep, fundamental research to identify long-term investments for high net worth and institutional investors. Their approach focuses on companies that are misunderstood or mispriced, leveraging the unique perspective of practicing physicians to uncover competitive advantages. The firm's investment strategy involves a disciplined, bottoms-up approach, avoiding consensus opinion and focusing on companies that may be overlooked due to their limited impact on major indices. They do not use outside research, maintaining independent and original thought in their investment decisions. Located in Palo Alto, California, between Stanford University and Silicon Valley, Palo Alto Investors LP is situated in a hub of innovation and entrepreneurship. This proximity provides access to world-class researchers, disruptive technologists, and leading venture capitalists, offering unique opportunities to tap into resources that are envied by many on Wall Street.
Investment Focus
- Accredited Investor
- Qualified Purchaser
Portfolio Companies
Reach Palo Alto Investors LP directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Palo Alto Investors LP
What sectors does Palo Alto Investors LP invest in?
Palo Alto Investors LP invests in Healthcare, and is based in California, United States. Palo Alto Investors LP is listed as a private investment firm in the ConnectSafely investor database.
What stage does Palo Alto Investors LP invest at?
Palo Alto Investors LP backs companies at Early Stage, Growth and Late Stage, writing cheques of 1M - 50M.
Which regions does Palo Alto Investors LP invest in?
Palo Alto Investors LP invests across United States.
What companies has Palo Alto Investors LP invested in?
Palo Alto Investors LP's portfolio includes AbbVie, Thermo Fisher Scientific, Amgen, Bristol-Myers Squibb and Medtronic.
Last updated · Source: ConnectSafely investor database
